- Home
- JELD vs LAB Comparison
JELD vs LAB Comparison
Compare JELD & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JELD
- LAB
- Stock Information
- Founded
- JELD 1960
- LAB 1999
- Country
- JELD United States
- LAB United States
- Employees
- JELD N/A
- LAB N/A
- Industry
- JELD Forest Products
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- JELD Basic Materials
- LAB Industrials
- Exchange
- JELD Nasdaq
- LAB Nasdaq
- Market Cap
- JELD 326.7M
- LAB 372.1M
- IPO Year
- JELD 2017
- LAB 2011
- Fundamental
- Price
- JELD $4.60
- LAB $1.34
- Analyst Decision
- JELD Hold
- LAB Buy
- Analyst Count
- JELD 8
- LAB 2
- Target Price
- JELD $7.34
- LAB $2.50
- AVG Volume (30 Days)
- JELD 1.5M
- LAB 2.8M
- Earning Date
- JELD 08-04-2025
- LAB 07-30-2025
- Dividend Yield
- JELD N/A
- LAB N/A
- EPS Growth
- JELD N/A
- LAB N/A
- EPS
- JELD N/A
- LAB N/A
- Revenue
- JELD $3,592,472,000.00
- LAB $169,687,000.00
- Revenue This Year
- JELD N/A
- LAB N/A
- Revenue Next Year
- JELD $3.40
- LAB $12.18
- P/E Ratio
- JELD N/A
- LAB N/A
- Revenue Growth
- JELD N/A
- LAB 33.86
- 52 Week Low
- JELD $3.27
- LAB $0.92
- 52 Week High
- JELD $17.70
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- JELD 62.46
- LAB 58.76
- Support Level
- JELD $4.18
- LAB $1.27
- Resistance Level
- JELD $4.56
- LAB $1.41
- Average True Range (ATR)
- JELD 0.22
- LAB 0.11
- MACD
- JELD 0.09
- LAB 0.01
- Stochastic Oscillator
- JELD 97.68
- LAB 50.00
About JELD JELD-WEN Holding Inc.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential single and multi-family homes and non-residential buildings. The firm's operating segments are North America, Europe, and Australasia. It generates a majority of its revenue from North America.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.